Financial News
All News about Hillstream BioPharma, Inc. - Common Stock
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_394.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_122.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2676.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_393.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
February 14, 2022
From Hillstream BioPharma
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
![](https://talkmarkets.com/user_content/ckimages/orig_46090766321_9ae7b253d1_c.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/biotech2_4.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
From Hillstream BioPharma
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
From Hillstream BioPharma
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_375.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1123.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/penny-stocks-insider-trade_108.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/biotech3_2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_2.jpg)
![](https://live.staticflickr.com/4865/32641567148_2fc9c5ea06_n.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
Hillstream BioPharma Announces Closing of Initial Public Offering
January 14, 2022
From Hillstream BioPharma
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_371.png)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_532.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_399.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/22193.png?v=0)
Hillstream BioPharma Announces Pricing of Initial Public Offering
January 11, 2022
From Hillstream BioPharma
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.